Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
WuXi AppTec SHSE:603259 |
303,29 B | 29,04% | 6/6 | 16,77% | 42,31% | 35,01% | UP |
|
WuXi Biologics (Cayman) SEHK:2269 |
144,73 B | 31,93% | 6/6 | 12,45% | 70,67% | 29,30% | UP |
|
Pharmaron Beijing SZSE:300759 |
50,92 B | 20,79% | 5/6 | 31,44% | 70,79% | 30,70% | UP |
|
Hangzhou Tigermed Consulting SZSE:300347 |
45,10 B | 10,66% | 4/6 | 21,16% | 55,81% | 21,88% | DOWN |
|
XtalPi Holdings SEHK:2228 |
41,31 B | 465,97% | 1/2 | -31,66% | -38,60% | 12,50% | UP |
|
Joinn Laboratories(China)Co.,Ltd. SHSE:603127 |
24,93 B | 5,25% | 3/5 | 145,04% | -57,18% | 0,00% | UP |
|
Genscript Biotech SEHK:1548 |
27,03 B | 13,53% | 3/6 | 58,57% | 23,33% | 41,83% | DOWN |
|
HitGen SHSE:688222 |
10,45 B | 27,40% | 6/6 | 44,14% | 58,26% | 4,02% | UP |
|
PharmaBlock Sciences (Nanjing) SZSE:300725 |
8,64 B | 13,56% | 3/5 | 267,34% | 17,47% | -100,00% | DOWN |
|
Shanghai Medicilon SHSE:688202 |
8,41 B | 0,00% | 1/5 | 0,00% | 22,17% | -100,00% | UP |
|
Shanghai Runda Medical Technology SHSE:603108 |
7,40 B | -14,23% | 2/5 | 20,49% | -11,91% | 63,13% | DOWN |
|
Beijing Sun-Novo Pharmaceutical Research SHSE:688621 |
7,17 B | 0,00% | 0/0 | 240,75% | -12,90% | -100,00% | UP |
|
Novogene SHSE:688315 |
5,63 B | -1,36% | 4/6 | 127,16% | 21,88% | 14,60% | DOWN |
|
R&G PharmaStudies SZSE:301333 |
6,27 B | 0,34% | 0/0 | 9,78% | -14,80% | 27,86% | UP |
|
PharmaResources (Shanghai) SZSE:301230 |
5,64 B | 0,00% | 0/0 | 194,48% | -54,73% | -100,00% | UP |
|
Hangzhou Bio-Sincerity Pharma-Tech SZSE:301096 |
5,53 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
|
SMO ClinPlus CO.,LTD. SZSE:301257 |
4,65 B | 0,00% | 0/0 | 0,00% | 0,00% | -46,73% | UP |
|
Shanghai Obio Technology (Group) Corp. SHSE:688238 |
4,41 B | 0,00% | 0/0 | 35,30% | 0,00% | 65,86% | DOWN |
|
Boji Medical Technology SZSE:300404 |
3,82 B | 0,00% | 0/0 | 102,31% | 16,92% | -100,00% | UP |
|
Viva Biotech Holdings SEHK:1873 |
4,16 B | -13,50% | 2/4 | 0,00% | -542,64% | 42,13% | UP |
